CNBX Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	May '25 May 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2016 - 2020
Revenue	-	0.13	0.41	0.03	-	0.01	Upgrade
Revenue Growth (YoY)	-	-68.29%	1269.13%	-	-	-27.29%	Upgrade
Gross Profit	-	0.13	0.41	0.03	-	0.01	Upgrade
Selling, General & Admin	0.27	0.52	0.91	1.8	0.83	1.37	Upgrade
Research & Development	-0.07	0.19	0.43	1.18	1.77	1.68	Upgrade
Operating Expenses	0.19	0.71	1.34	2.98	2.6	3.05	Upgrade
Operating Income	-0.19	-0.58	-0.93	-2.95	-2.6	-3.04	Upgrade
Interest Expense	-0.03	-0.02	-0	-0	-0	-0.01	Upgrade
Currency Exchange Gain (Loss)	-0	-0	0	-0.06	-0.02	-0.06	Upgrade
Other Non Operating Income (Expenses)	-	-	-0.05	-0.72	-0.96	-4.42	Upgrade
EBT Excluding Unusual Items	-0.22	-0.61	-0.98	-3.74	-3.59	-7.54	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0.2	0.07	Upgrade
Gain (Loss) on Sale of Assets	-	-0.09	-2.73	0.01	0.2	-	Upgrade
Pretax Income	-0.22	-0.7	-3.71	-3.72	-3.19	-7.47	Upgrade
Earnings From Continuing Operations	-0.22	-0.7	-3.71	-3.72	-3.19	-7.47	Upgrade
Net Income	-0.22	-0.7	-3.71	-3.72	-3.19	-7.47	Upgrade
Net Income to Common	-0.22	-0.7	-3.71	-3.72	-3.19	-7.47	Upgrade
Shares Outstanding (Basic)	34	30	9	1	1	1	Upgrade
Shares Outstanding (Diluted)	34	30	9	1	1	1	Upgrade
Shares Change (YoY)	21.59%	242.76%	621.77%	5.92%	2.95%	1.59%	Upgrade
EPS (Basic)	-0.01	-0.02	-0.42	-3.05	-2.77	-6.66	Upgrade
EPS (Diluted)	-0.01	-0.02	-0.42	-3.05	-2.77	-6.66	Upgrade
Free Cash Flow	-0.19	-0.25	-0.11	-1.68	-2.49	-2.85	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-1.38	-2.16	-2.54	Upgrade
Gross Margin	-	100.00%	100.00%	100.00%	-	100.00%	Upgrade
Operating Margin	-	-448.31%	-227.07%	-9860.37%	-	-42524.13%	Upgrade
Profit Margin	-	-534.46%	-904.57%	-12428.23%	-	-104337.91%	Upgrade
Free Cash Flow Margin	-	-188.71%	-27.43%	-5610.68%	-	-39830.98%	Upgrade
EBITDA	-0.14	-0.51	-0.77	-2.76	-2.38	-2.83	Upgrade
EBITDA Margin	-	-	-187.56%	-	-	-	Upgrade
D&A For EBITDA	0.05	0.07	0.16	0.2	0.22	0.22	Upgrade
EBIT	-0.19	-0.58	-0.93	-2.95	-2.6	-3.04	Upgrade
EBIT Margin	-	-	-227.07%	-	-	-	Upgrade

Updated Jan 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.